Tower Research Capital LLC (TRC) - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 161 filers reported holding AKERO THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$366,961
+1543.4%
15,642
+1669.5%
0.01%
+500.0%
Q1 2024$22,330
-75.8%
884
-77.6%
0.00%0.0%
Q4 2023$92,093
+74.1%
3,944
+277.1%
0.00%
-50.0%
Q3 2023$52,907
-43.3%
1,046
-47.6%
0.00%
-33.3%
Q2 2023$93,287
+62091.3%
1,998
-49.2%
0.00%
-40.0%
Q1 2023$150
+29.3%
3,935
+84.5%
0.01%0.0%
Q4 2022$116
-99.7%
2,133
+106.9%
0.01%
+400.0%
Q3 2022$35,000
-54.5%
1,031
-87.4%
0.00%
-50.0%
Q2 2022$77,000
-76.5%
8,167
-64.6%
0.00%
-33.3%
Q1 2022$328,000
+786.5%
23,058
+1215.3%
0.00%
+200.0%
Q4 2021$37,000
-7.5%
1,753
-2.1%
0.00%0.0%
Q3 2021$40,000
-41.2%
1,791
-34.9%
0.00%
-50.0%
Q2 2021$68,000
+161.5%
2,752
+211.3%
0.00%
Q1 2021$26,000
-73.5%
884
-76.8%
0.00%
-100.0%
Q4 2020$98,000
+100.0%
3,806
+141.2%
0.00%
+200.0%
Q3 2020$49,000
+28.9%
1,578
+2.3%
0.00%
-50.0%
Q2 2020$38,000
+171.4%
1,542
+126.1%
0.00%
+100.0%
Q1 2020$14,000
-79.4%
682
-77.6%
0.00%
-83.3%
Q4 2019$68,000
+161.5%
3,049
+120.8%
0.01%
+200.0%
Q2 2019$26,0001,3810.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
University of Wisconsin Foundation 423,849$9,943,49811.19%
Propel Bio Management, LLC 327,752$7,689,0624.99%
GENERAL ATLANTIC, L.P. 5,233,989$122,789,3823.86%
SILVERARC CAPITAL MANAGEMENT, LLC 625,087$14,664,5413.46%
Yiheng Capital Management, L.P. 1,434,179$33,645,8392.71%
Redmile Group, LLC 1,614,473$37,875,5372.29%
Boxer Capital, LLC 1,676,733$39,336,1562.07%
RTW INVESTMENTS, LP 5,431,985$127,434,3681.97%
Logos Global Management LP 800,000$18,768,0001.52%
MPM BioImpact LLC 385,990$9,055,3251.41%
View complete list of AKERO THERAPEUTICS INC shareholders